PM
IPSC icon

Parametrica Management’s Century Therapeutics IPSC Stock Holding History

Parametrica Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.2K Hold
27,840
– – 0.05% 19
2026
Q1 		$62.9K Hold
27,840
– – 0.07% 19
2025
Q4 		$27.7K Hold
27,840
– – 0.04% 21
2025
Q3 		$13.9K Hold
27,840
– – 0.02% 23
2025
Q2 		$15.6K Hold
27,840
– – 0.03% 27
2025
Q1 		$13.3K Hold
27,840
– – 0.02% 23
2024
Q4 		$28.1K Hold
27,840
– – 0.04% 65
2024
Q3 		$47.6K Hold
27,840
– – 0.06% 62
2024
Q2 		$71K Hold
27,840
– – 0.09% 20
2024
Q1 		$116K Hold
27,840
– – 0.17% 22
2023
Q4 		$92.4K Hold
27,840
– – 0.15% 26
2023
Q3 		$55.7K Hold
27,840
– – 0.09% 29
2023
Q2 		$88K Hold
27,840
– – 0.17% 26
2023
Q1 		$96.6K Hold
27,840
– – 0.17% 24
2022
Q4 		$143K Hold
27,840
– – 0.29% 35
2022
Q3 		$275K Sell
27,840
-1,015
-4% -$10.7K 0.56% 40
2022
Q2 		$241K Buy
+28,855
New +$283K 0.26% 103
2022
Q1 		– Sell
-28,855
Closed -$459K – 241
2021
Q4 		$459K Buy
28,855
+100
+0.3% +$1.88K 0.46% 36
2021
Q3 		$723K Buy
+28,755
New +$778K 0.54% 39

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Parametrica Management's IPSC Position: Q2 2026 in Review

Parametrica Management held its Century Therapeutics (IPSC) position steady in Q2 2026 at 27,840 shares worth $68.2K. The position accounts for 0.05% of the portfolio, ranked #19.

Parametrica Management first reported a position in IPSC in Q3 2021 and has held it in 19 quarters since. The position peaked at $723K in Q3 2021. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Parametrica Management held 27,840 shares of Century Therapeutics worth $68.2K as of Q2 2026.
  • Parametrica Management left its Century Therapeutics share count unchanged in Q2 2026.
  • Century Therapeutics made up 0.05% of Parametrica Management's portfolio in Q2 2026, its #19 holding.
  • Parametrica Management first reported a position in Century Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Parametrica Management's Century Therapeutics position peaked at $723K in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Parametrica Management's 13F filing for Q2 2026, filed 12 Aug 2026.